Across TCGA pan-cancer cohorts, TRIM43CP RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of TRIM43CP’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where TRIM43CP RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TRIM43CP is over-expressed in tumor.
LUAD and LUSC are the cancer types where TRIM43CP tumor–normal differential expression is most reproducible.